{
  "id": "597c5887-858b-4e6a-afb2-bdfa15dfb22e",
  "answer": "Ultragenyx Pharmaceutical Inc. has a not yet measurable company news read. Its latest completed weekly trend is negative.",
  "status": "insufficient",
  "as_of": "2026-08-01T08:17:48.008579+00:00",
  "period_end": "2026-08-14",
  "scope": "company and instrument",
  "subject": {
    "type": "ticker",
    "key": "SAO:R2AR34",
    "name": "Ultragenyx Pharmaceutical Inc. (R2AR34)",
    "identity": {
      "sharemaestro_id": "62a5460f-1b30-4614-a90f-00d675677e6d",
      "canonical_name": "Ultragenyx Pharmaceutical Inc.",
      "isin": null,
      "lei": null,
      "cik": null,
      "website": null,
      "aliases": [
        "R2AR34"
      ],
      "provider_symbols": {
        "eodhd": [
          "R2AR34.SA"
        ],
        "yahoo": "R2AR34.SA",
        "market": "SAO",
        "alpha_vantage": null
      },
      "same_as": []
    }
  },
  "coverage": {
    "country": "Brazil",
    "sector": "Healthcare",
    "industry": "Biotechnology"
  },
  "score": 47.0,
  "confidence": 0,
  "evidence_count": 8,
  "independent_sources": 7,
  "freshest_evidence": null,
  "previous_read": 45.0,
  "change": 2.0,
  "method_version": "public-evidence-1",
  "facts": {
    "sector": "Healthcare",
    "ticker": "R2AR34",
    "company": "Ultragenyx Pharmaceutical Inc.",
    "country": "Brazil",
    "currency": "BRL",
    "exchange": "SAO",
    "industry": "Biotechnology",
    "week_end": "2026-08-14",
    "asset_type": "equity",
    "news_count": 8,
    "trend_state": "negative",
    "latest_close": "12.870000",
    "score_change": 2.0,
    "weekly_change": 0.0,
    "evidence_status": "insufficient",
    "sentiment_score": 47
  },
  "canonical_url": "https://sharemaestro.com/evidence/597c5887-858b-4e6a-afb2-bdfa15dfb22e/",
  "evidence_urls": [
    {
      "label": "Company chart",
      "url": "https://sharemaestro.com/terminal/62a5460f-1b30-4614-a90f-00d675677e6d/"
    },
    {
      "label": "Company news sentiment",
      "url": "https://sharemaestro.com/sentiment/62a5460f-1b30-4614-a90f-00d675677e6d/"
    },
    {
      "label": "Current financial news",
      "url": "https://sharemaestro.com/newsreel/search/?ticker=R2AR34"
    }
  ],
  "limitations": "This is dated market research. Coverage may be delayed, incomplete or unavailable.",
  "record_hash": "b576912aac1346f9f067fe7ccbc3c9e49a22118b503388a4806e413206ee42ef",
  "citation": "Sharemaestro, Ultragenyx Pharmaceutical Inc. (R2AR34), 2026-08-01, https://sharemaestro.com/evidence/597c5887-858b-4e6a-afb2-bdfa15dfb22e/"
}